Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 2, 2008, Pages 429-435

  Haralabidis, S ^a   Diakou, A ^a   Frydas, S ^a   Papadopoulos, E ^a   Mylonas, A ^b   Patsias, A ^c   Roilides, E ^a   Giannoulis, E ^d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b 424 General Military Hospital   (Greece)

^c Gennimatas General Hospital   (Greece)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Albendazole; Follow up; Hydatidosis; IgA; IgE; IgG; IgM; Praziquantel

Indexed keywords

ALBENDAZOLE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PRAZIQUANTEL;

ANTIBODY DETECTION; ARTICLE; CALCIFICATION; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ECHINOCOCCOSIS; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; HYDATID CYST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 47249141230     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100223     Document Type: Article

References (23)

1. Ozyazicioglu A, Kocak H, Ceviz M, Balci AY. Surgical treatment of echinococcal disease of the heart: report of 3 cases. Asian Cariovasc Thorac Ann 2002; 10:66-70.
2. Babba H, Messedi A, Masmoudi S, Zribi M, Grillot R, Ambriose-Thomas P, Beyrouti I, Sahnoun Y. Diagnosis of human hydatidosis: Comparison between imagery and six serologic techniques. Am J Trop Med Hyg 1994; 50:64-8.
3. Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 1989; 83:97-102.
4. Avgerinos ED, Pavlakis E, Stathoulopoulos A, Manoukas E, Skarpas G, Tsatsoulis P. Clinical presentations and surgical management of liver hydatidosis: our 20 year experience. HPB: Official Journal of the Intern. HPB Assoc. 2006; 8:189-94.
5. Salmot AG, Cremieux AC, Hay JM, Meulemans A, Giovanangeli MD, Delaitre B, Coulaud JP. Albendazole as a potential treatment for human hydatidosis. Lancet 1983; 9:65256.
6. Morris DL. Albendazole treatment of hydatid disease-follow-up at 5 years. Trop Doct 1989; 19:179-83.
7. Yasawy MI, Al Karawi MA, Mohamed ARE. Combination of praziquantel and albendazole in the treatment of hydatid disease. Trop Med Parasitol 1993; 44:192-97.
8. Haralabidis S, Karagouni E, Frydas S, Dotsika E. Immunoglobulin and cytokine profile in murine secondary hydatidosis. Parasite Immunol 1995; 17:625-31.
9. Nahmias J, Goldsmith R, Soibelman M, EL-On J. Three to 7-year follow up after albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease). Ann Trop Med Parasitol 1994; 88:295-9.
10. Kern P. Echinococcus granulosus infection: clinical presentation, medical treatment and outcome. Langenbecks Arch Surg 2003; 388:413-8.
11. WHO/OIE. 2001. Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. J. Eckert, M.A. Gemmell, F.X. Meslin, Z.S. Pawlowski, eds. Geneva: World Health Organization, p. 1.
12. Ayles HM, Corbett EL, Taylor I, Cowie AG, Bligh J, Walmsley K, Bryceson AD. A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London. Ann R Coll Surg Engl 2002; 84:100-8.
13. Lightowlers MW, Gottstein B. Echinococcosis/hydatidosis: antigens, immunological and molecular diagnosis. In The biology of Echinococcus and hydatid disease. 1995. R.C.A. Thompson and AJ. Lymbery, ed. CAB International, United Kingdom, Wallingford, p. 355.
14. Gollackner B, Langle F, Auer H et al. Radical surgical therapy of abdominal cystic hydatid disease: factors of recurrence. World J Surg 2000; 24:717-22.
15. Horton J. Albendazole for the treatment of echinococcosis. Fundam Clin Pharmacol 2003; 17:205-9.
16. Chai J, Menghebat, J. Wei et al. Observations on clinical efficacy of albendazole emulsion in 264 cases of hepatic cystic echinococcosis. Parasitol Int 2004; 53:3-9.
17. Keshmiri M, Baharvahdat H, Fattahi SH, Davachi B, Dabiri RH, Baradaran H, Rajabzadeh F. Albendazole versus placebo in treatment of echinococcosis. Trans R Soc Trop Med Hyg 2001; 95:190-5.
18. Todorov T, Vutova K, Donev S, Ivanov A, Katzarov K, Takov D. The types and timing of the degenerative changes seen in the cysts during and after benzimidazole treatment of cystic echinococcosis. Ann Trop Med Parasitol 2005; 99:649-53.
19. Saimot AG. Medical treatment of liver hydatidosis. World J Surg 2001; 25:15-19.
20. Todorov T, Mechkov G, Vutova K, Georgiev P, Lazarova I, Tonchev Z, Nedelkow G. Factors influencing the response to chemotherapy in human cystic echinococcosis. Bull WHO 1992; 70:347-52.
21. Doiz O, Benito R, Gil J, Rojas A, Rubio MC, Osuna A. Pre- and postsurgical detection of IgG, IgM, and IgA specific to hydatidosis by ELISA with purified antigen enriched with the 5/B antigen complex. J Clin Lab Anal 2002; 16:295-9.
22. Rigano R, Ioppolo S, Ortona E, Margutti P, Profumo E, Ali MD, Di Vico B, Teggi A, Siracusano A. Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates. Clin Exp Immunol 2002; 129:485-91.
23. Galitza Z., Bazarsky E, Sneier R, Peiser J, El-On J. Repeated treatment of cystic echinococcosis in patients with a long-term immunological response after successful surgical cyst removal. Trans R Soc Trop Med Hyg 2006; 100:126-31.